Page 30 - P4403.59-V45_Numark Magazine November 23.
P. 30

YOUR QUERIES





               ASK                                    Our Information

                                                      Services agony aunt
               SUE                                    Sue Swift shares your


                                                      recent queries around
                                                      The Drug Tariff.











               Remember - Information Services are here to offer a helping hand whenever you need them.
                    Let us do the work so you can concentrate on helping your team and your patients.



                               Q: Can you tell me more about Elvanse® vs. Elvanse Adult®
                               Capsules?




                  A: I’m often asked about the differences between Elvanse®
                  capsules and Elvanse® Adult capsules.

                  Both products contain Lisdexamfetamine dimesylate and have
                  the same formulation, strengths and presentation, but have
                  different licensed indications as outlined below:



                                              Elvanse® Capsules                    Elvanse® Adult Capsules

               Active ingredient                  Lisdexamfetamine dimesylate          Lisdexamfetamine dimesylate

               Licensed age range                6 years old to up to 18 years old        18 years old and above

                                              As part of a comprehensive treatment
                                                 programme for attention deficit/
                                                 hyperactivity disorder (ADHD) in
                                               children aged 6 years and over when
                                              response to previous methylphenidate      As part of a comprehensive
               Licensed indication               treatment is considered clinically   treatment programme for attention
                                                          inadequate.              deficit/hyperactivity disorder (ADHD)
                                              Elvanse should not be used in children            in adults.
                                               under the age of 6 years. Safety and
                                                efficacy in this age group has not
                                                        been established.
                                               If treatment withdrawal has not been
                                                successful when an adolescent has
                                                reached 18 years of age continued    For children and adolescents aged
                                                treatment into adulthood may be        6 to 17 years, another product
               Additional information
                                                  necessary. The need for further      containing lisdexamfetamine
                                               treatment of these adults should be        dimesylate is available.
                                                reviewed regularly and undertaken
                                                            annually.
                                                                         Reference: https://www.medicines.org.uk/emc


                30


                                                                                                                 12/10/2023   12:03:04
         P4403.59-V45_Numark Magazine November 23. ANT 11-10-23.indd   30                                        12/10/2023   12:03:04
         P4403.59-V45_Numark Magazine November 23. ANT 11-10-23.indd   30
   25   26   27   28   29   30   31   32   33   34   35